PDB Short entry for 3ZTC HEADER TRANSCRIPTION 06-JUL-11 3ZTC TITLE PVHL54-213-ELOB-ELOC COMPLEX _ (2S,4R)-N-((1,1'-BIPHENYL)-4-YLMETHYL)- TITLE 2 4-HYDROXY-1-(2-(3-METHYLISOXAZOL-5-YL)ACETYL)PYRROLIDINE-2- TITLE 3 CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; COMPND 3 CHAIN: A, D, G, J; COMPND 4 SYNONYM: ELONGIN 18 KDA SUBUNIT, ELONGIN-B, ELOB, RNA POLYMERASE II COMPND 5 TRANSCRIPTION FACTOR SIII SUBUNIT B, SIII P18, ELONGINB; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; COMPND 9 CHAIN: B, E, H, K; COMPND 10 SYNONYM: ELONGIN 15 KDA SUBUNIT, ELONGIN-C, ELOC, RNA POLYMERASE II COMPND 11 TRANSCRIPTION FACTOR SIII SUBUNIT C, SIII P15, ELONGINC; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR; COMPND 15 CHAIN: C, F, I, L; COMPND 16 FRAGMENT: RESIDUES 54-213; COMPND 17 SYNONYM: PROTEIN G7, PVHL; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCDF-DUET1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PCDF-DUET1; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS TRANSCRIPTION, TUMOUR SUPRESSOR PROTEIN, CHRONIC ANEAMIA TREATMENT, KEYWDS 2 E3 UBIQUITIN LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR I.VAN MOLLE,D.L.BUCKLEY,C.M.CREWS,A.CIULLI REVDAT 4 20-DEC-23 3ZTC 1 REMARK REVDAT 3 20-DEC-17 3ZTC 1 AUTHOR REVDAT 2 14-NOV-12 3ZTC 1 AUTHOR JRNL REVDAT 1 25-JUL-12 3ZTC 0 JRNL AUTH I.VAN MOLLE,A.THOMANN,D.L.BUCKLEY,E.C.SO,S.LANG,C.M.CREWS, JRNL AUTH 2 A.CIULLI JRNL TITL DISSECTING FRAGMENT-BASED LEAD DISCOVERY AT THE VON JRNL TITL 2 HIPPEL-LINDAU PROTEIN:HYPOXIA INDUCIBLE FACTOR 1ALPHA JRNL TITL 3 PROTEIN-PROTEIN INTERFACE. JRNL REF CHEM.BIOL. V. 19 1300 2012 JRNL REFN ISSN 1074-5521 JRNL PMID 23102223 JRNL DOI 10.1016/J.CHEMBIOL.2012.08.015 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 46837 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.243 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.317 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2427 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3415 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE SET COUNT : 102 REMARK 3 BIN FREE R VALUE : 0.4170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10330 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.962 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.405 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.303 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.093 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.868 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10701 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 14560 ; 1.716 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1308 ; 7.849 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 451 ;38.089 ;23.215 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1708 ;19.930 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 80 ;19.439 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1661 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8137 ; 0.008 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6694 ; 0.774 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 10843 ; 1.472 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4007 ; 2.036 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3717 ; 3.408 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY. REMARK 4 REMARK 4 3ZTC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1290048922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : HORIZONTALLY SIDE DIFFRACTING REMARK 200 SILICON 111 CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49241 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 0.58000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3ZRF REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M NA CITRATE PH 5.7, 0.2 M MG REMARK 280 ACETATE, 15% PEG8000, 50MM DTT. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 183.36200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.68100 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 275.04300 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 183.36200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 275.04300 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 91.68100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 82 REMARK 465 PRO A 105 REMARK 465 GLN A 106 REMARK 465 ASP A 107 REMARK 465 SER A 108 REMARK 465 GLY A 109 REMARK 465 SER A 110 REMARK 465 SER A 111 REMARK 465 ALA A 112 REMARK 465 ASN A 113 REMARK 465 GLU A 114 REMARK 465 GLN A 115 REMARK 465 ALA A 116 REMARK 465 VAL A 117 REMARK 465 GLN A 118 REMARK 465 MET B 16 REMARK 465 GLY B 48 REMARK 465 PRO B 49 REMARK 465 GLY B 50 REMARK 465 GLN B 51 REMARK 465 PHE B 52 REMARK 465 ALA B 53 REMARK 465 GLU B 54 REMARK 465 ASN B 55 REMARK 465 GLU B 56 REMARK 465 THR B 57 REMARK 465 GLY C 51 REMARK 465 SER C 52 REMARK 465 HIS C 53 REMARK 465 MET C 54 REMARK 465 GLU C 55 REMARK 465 ALA C 56 REMARK 465 GLY C 57 REMARK 465 ARG C 58 REMARK 465 PRO C 59 REMARK 465 ARG C 60 REMARK 465 PRO C 61 REMARK 465 VAL C 62 REMARK 465 VAL C 142 REMARK 465 ARG C 205 REMARK 465 ILE C 206 REMARK 465 ALA C 207 REMARK 465 HIS C 208 REMARK 465 GLN C 209 REMARK 465 ARG C 210 REMARK 465 MET C 211 REMARK 465 GLY C 212 REMARK 465 ASP C 213 REMARK 465 ALA D 81 REMARK 465 ASP D 82 REMARK 465 VAL D 102 REMARK 465 MET D 103 REMARK 465 LYS D 104 REMARK 465 PRO D 105 REMARK 465 GLN D 106 REMARK 465 ASP D 107 REMARK 465 SER D 108 REMARK 465 GLY D 109 REMARK 465 SER D 110 REMARK 465 SER D 111 REMARK 465 ALA D 112 REMARK 465 ASN D 113 REMARK 465 GLU D 114 REMARK 465 GLN D 115 REMARK 465 ALA D 116 REMARK 465 VAL D 117 REMARK 465 GLN D 118 REMARK 465 MET E 16 REMARK 465 PRO E 49 REMARK 465 GLY E 50 REMARK 465 GLN E 51 REMARK 465 PHE E 52 REMARK 465 ALA E 53 REMARK 465 GLU E 54 REMARK 465 ASN E 55 REMARK 465 GLU E 56 REMARK 465 THR E 57 REMARK 465 GLY F 51 REMARK 465 SER F 52 REMARK 465 HIS F 53 REMARK 465 MET F 54 REMARK 465 GLU F 55 REMARK 465 ALA F 56 REMARK 465 GLY F 57 REMARK 465 ARG F 58 REMARK 465 PRO F 59 REMARK 465 ARG F 60 REMARK 465 PRO F 61 REMARK 465 VAL F 62 REMARK 465 ARG F 205 REMARK 465 ILE F 206 REMARK 465 ALA F 207 REMARK 465 HIS F 208 REMARK 465 GLN F 209 REMARK 465 ARG F 210 REMARK 465 MET F 211 REMARK 465 GLY F 212 REMARK 465 ASP F 213 REMARK 465 GLN G 106 REMARK 465 ASP G 107 REMARK 465 SER G 108 REMARK 465 GLY G 109 REMARK 465 SER G 110 REMARK 465 SER G 111 REMARK 465 ALA G 112 REMARK 465 ASN G 113 REMARK 465 GLU G 114 REMARK 465 GLN G 115 REMARK 465 ALA G 116 REMARK 465 VAL G 117 REMARK 465 GLN G 118 REMARK 465 MET H 16 REMARK 465 PRO H 49 REMARK 465 GLY H 50 REMARK 465 GLN H 51 REMARK 465 PHE H 52 REMARK 465 ALA H 53 REMARK 465 GLU H 54 REMARK 465 ASN H 55 REMARK 465 GLU H 56 REMARK 465 THR H 57 REMARK 465 SER H 87 REMARK 465 GLY I 51 REMARK 465 SER I 52 REMARK 465 HIS I 53 REMARK 465 MET I 54 REMARK 465 GLU I 55 REMARK 465 ALA I 56 REMARK 465 GLY I 57 REMARK 465 ARG I 58 REMARK 465 PRO I 59 REMARK 465 ARG I 60 REMARK 465 PRO I 61 REMARK 465 ALA I 207 REMARK 465 HIS I 208 REMARK 465 GLN I 209 REMARK 465 ARG I 210 REMARK 465 MET I 211 REMARK 465 GLY I 212 REMARK 465 ASP I 213 REMARK 465 PRO J 105 REMARK 465 GLN J 106 REMARK 465 ASP J 107 REMARK 465 SER J 108 REMARK 465 GLY J 109 REMARK 465 SER J 110 REMARK 465 SER J 111 REMARK 465 ALA J 112 REMARK 465 ASN J 113 REMARK 465 GLU J 114 REMARK 465 GLN J 115 REMARK 465 ALA J 116 REMARK 465 VAL J 117 REMARK 465 GLN J 118 REMARK 465 MET K 16 REMARK 465 PRO K 49 REMARK 465 GLY K 50 REMARK 465 GLN K 51 REMARK 465 PHE K 52 REMARK 465 ALA K 53 REMARK 465 GLU K 54 REMARK 465 ASN K 55 REMARK 465 GLU K 56 REMARK 465 THR K 57 REMARK 465 GLY L 51 REMARK 465 SER L 52 REMARK 465 HIS L 53 REMARK 465 MET L 54 REMARK 465 GLU L 55 REMARK 465 ALA L 56 REMARK 465 GLY L 57 REMARK 465 ARG L 58 REMARK 465 PRO L 59 REMARK 465 ARG L 60 REMARK 465 PRO L 61 REMARK 465 ARG L 205 REMARK 465 ILE L 206 REMARK 465 ALA L 207 REMARK 465 HIS L 208 REMARK 465 GLN L 209 REMARK 465 ARG L 210 REMARK 465 MET L 211 REMARK 465 GLY L 212 REMARK 465 ASP L 213 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 65 CG CD OE1 NE2 REMARK 470 ARG A 68 CZ NH1 NH2 REMARK 470 ASP A 83 CG OD1 OD2 REMARK 470 GLU A 91 CG CD OE1 OE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 LEU A 99 CG CD1 CD2 REMARK 470 ASP A 101 CG OD1 OD2 REMARK 470 MET A 103 CG SD CE REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 LYS B 43 CG CD CE NZ REMARK 470 LEU B 46 CG CD1 CD2 REMARK 470 SER B 47 OG REMARK 470 ASN B 58 CG OD1 ND2 REMARK 470 ARG B 63 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 64 CZ NH1 NH2 REMARK 470 GLN C 73 CG CD OE1 NE2 REMARK 470 GLN C 96 CG CD OE1 NE2 REMARK 470 THR C 133 OG1 CG2 REMARK 470 GLU C 134 CG CD OE1 OE2 REMARK 470 ASP C 143 CG OD1 OD2 REMARK 470 GLN C 145 CG CD OE1 NE2 REMARK 470 VAL C 170 CG1 CG2 REMARK 470 LYS C 171 CG CD CE NZ REMARK 470 GLU C 173 CG CD OE1 OE2 REMARK 470 ASN C 174 CG OD1 ND2 REMARK 470 ARG C 176 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 177 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 178 CG CD1 CD2 REMARK 470 TYR C 185 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN C 195 CG CD OE1 NE2 REMARK 470 LYS C 196 CG CD CE NZ REMARK 470 GLU C 199 CG CD OE1 OE2 REMARK 470 ARG C 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 201 CG CD1 CD2 REMARK 470 GLN C 203 CG CD OE1 NE2 REMARK 470 GLU C 204 CG CD OE1 OE2 REMARK 470 ARG D 9 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 40 CG OD1 OD2 REMARK 470 ARG D 43 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 48 CG OD1 OD2 REMARK 470 GLN D 65 CG CD OE1 NE2 REMARK 470 ARG D 80 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 83 CG OD1 OD2 REMARK 470 THR D 84 OG1 CG2 REMARK 470 PHE D 85 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE D 90 CG1 CG2 CD1 REMARK 470 GLU D 91 CG CD OE1 OE2 REMARK 470 GLU D 98 CG CD OE1 OE2 REMARK 470 LEU D 99 CG CD1 CD2 REMARK 470 SER E 47 OG REMARK 470 ASN E 58 CG OD1 ND2 REMARK 470 ARG E 63 CG CD NE CZ NH1 NH2 REMARK 470 ARG F 69 CG CD NE CZ NH1 NH2 REMARK 470 ARG F 113 NE CZ NH1 NH2 REMARK 470 THR F 133 OG1 CG2 REMARK 470 VAL F 142 CG1 CG2 REMARK 470 ASP F 143 CG OD1 OD2 REMARK 470 GLN F 145 CG CD OE1 NE2 REMARK 470 ARG F 177 NE CZ NH1 NH2 REMARK 470 ARG F 200 CG CD NE CZ NH1 NH2 REMARK 470 LEU F 201 CG CD1 CD2 REMARK 470 GLN F 203 CG CD OE1 NE2 REMARK 470 GLU F 204 CG CD OE1 OE2 REMARK 470 LYS G 36 CG CD CE NZ REMARK 470 GLN G 65 CG CD OE1 NE2 REMARK 470 ASP G 82 CG OD1 OD2 REMARK 470 ASP G 83 CG OD1 OD2 REMARK 470 THR G 84 OG1 CG2 REMARK 470 GLU G 98 CG CD OE1 OE2 REMARK 470 LEU G 99 CG CD1 CD2 REMARK 470 ASP G 101 CG OD1 OD2 REMARK 470 LYS G 104 CG CD CE NZ REMARK 470 LYS H 20 CG CD CE NZ REMARK 470 LYS H 43 CG CD CE NZ REMARK 470 SER H 47 OG REMARK 470 ASN H 58 CG OD1 ND2 REMARK 470 GLN I 73 CD OE1 NE2 REMARK 470 VAL I 142 CG1 CG2 REMARK 470 ASP I 143 CG OD1 OD2 REMARK 470 ARG I 182 CG CD NE CZ NH1 NH2 REMARK 470 GLN I 203 CG CD OE1 NE2 REMARK 470 GLU I 204 CG CD OE1 OE2 REMARK 470 ARG I 205 CG CD NE CZ NH1 NH2 REMARK 470 ILE I 206 CG1 CG2 CD1 REMARK 470 ASP J 82 CG OD1 OD2 REMARK 470 GLU J 98 CG CD OE1 OE2 REMARK 470 ASP J 101 CG OD1 OD2 REMARK 470 MET J 103 CG SD CE REMARK 470 LYS J 104 CG CD CE NZ REMARK 470 LYS K 43 CG CD CE NZ REMARK 470 SER K 47 OG REMARK 470 ARG L 64 CZ NH1 NH2 REMARK 470 GLN L 73 CG CD OE1 NE2 REMARK 470 VAL L 142 CG1 CG2 REMARK 470 ASP L 143 CG OD1 OD2 REMARK 470 GLN L 203 CG CD OE1 NE2 REMARK 470 GLU L 204 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU D 44 O LEU D 50 2.03 REMARK 500 O SER I 68 O HOH I 2001 2.09 REMARK 500 O LEU I 178 OH TYR I 185 2.15 REMARK 500 O GLY J 54 O HOH J 2003 2.16 REMARK 500 O HIS J 10 N THR J 12 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 100 C - N - CA ANGL. DEV. = 14.2 DEGREES REMARK 500 PRO A 100 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 PRO G 38 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 10 -105.96 49.22 REMARK 500 GLU A 41 30.16 -87.75 REMARK 500 ASP A 47 -125.14 49.08 REMARK 500 ALA A 71 62.45 -160.62 REMARK 500 ARG A 80 113.31 80.57 REMARK 500 THR A 84 130.49 140.35 REMARK 500 GLU A 98 -76.00 14.60 REMARK 500 LEU A 99 114.87 106.52 REMARK 500 PRO A 100 14.71 -55.27 REMARK 500 ASP A 101 -34.86 63.14 REMARK 500 VAL A 102 83.07 -67.64 REMARK 500 MET A 103 75.73 179.72 REMARK 500 LEU B 37 7.20 -65.53 REMARK 500 THR B 88 77.43 -36.54 REMARK 500 GLU B 89 128.76 -7.96 REMARK 500 ARG C 79 49.31 -89.63 REMARK 500 ASN C 90 161.26 -2.40 REMARK 500 SER C 111 -152.81 -132.65 REMARK 500 GLN C 132 -14.87 77.15 REMARK 500 GLN C 145 136.35 85.26 REMARK 500 VAL C 181 167.28 -47.43 REMARK 500 ASP C 190 48.51 -74.01 REMARK 500 HIS C 191 135.94 -29.12 REMARK 500 HIS D 10 -101.43 55.40 REMARK 500 PRO D 38 124.27 -28.60 REMARK 500 ASP D 47 98.39 32.76 REMARK 500 ASP D 48 -59.54 80.26 REMARK 500 LEU D 50 -72.52 -70.81 REMARK 500 LEU D 51 109.13 110.32 REMARK 500 ALA D 71 61.05 -164.23 REMARK 500 PRO D 97 -92.35 -89.15 REMARK 500 GLU D 98 -105.68 -104.42 REMARK 500 LEU D 99 -144.23 -101.94 REMARK 500 SER E 47 109.86 67.86 REMARK 500 SER E 67 -62.86 -22.17 REMARK 500 THR E 88 -126.69 -90.55 REMARK 500 ARG F 79 54.77 -92.44 REMARK 500 ASN F 90 160.33 -17.15 REMARK 500 PRO F 103 -89.59 -36.52 REMARK 500 SER F 111 -152.71 -131.88 REMARK 500 ASN F 131 55.90 39.06 REMARK 500 GLN F 132 -35.89 83.93 REMARK 500 THR F 133 -167.11 -109.35 REMARK 500 ASP F 143 92.81 -7.82 REMARK 500 ARG F 182 -37.87 -36.85 REMARK 500 ASN F 193 133.30 -170.32 REMARK 500 HIS G 10 -105.00 60.15 REMARK 500 ILE G 34 -74.05 -116.82 REMARK 500 LYS G 36 73.95 49.83 REMARK 500 ARG G 37 96.57 -173.17 REMARK 500 REMARK 500 THIS ENTRY HAS 97 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU G 98 LEU G 99 40.42 REMARK 500 GLY I 104 THR I 105 -138.52 REMARK 500 ASP J 83 THR J 84 30.24 REMARK 500 SER K 87 THR K 88 146.55 REMARK 500 GLY L 104 THR L 105 -142.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TR0 I 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TR0 C 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TR0 F 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TR0 L 1205 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN- B AND ELONGIN- REMARK 900 C AT 1.9A RESOLUTION REMARK 900 RELATED ID: 1LQB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HYDROXYLATED HIF-1 ALPHA PEPTIDEBOUND TO THE REMARK 900 PVHL/ELONGIN-C/ELONGIN-B COMPLEX REMARK 900 RELATED ID: 3ZRF RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX_APO REMARK 900 RELATED ID: 1VCB RELATED DB: PDB REMARK 900 THE VHL-ELONGINC-ELONGINB STRUCTURE REMARK 900 RELATED ID: 1LM8 RELATED DB: PDB REMARK 900 STRUCTURE OF A HIF-1A-PVHL-ELONGINB-ELONGINC COMPLEX REMARK 900 RELATED ID: 2IZV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN- B AND ELONGIN- REMARK 900 C AT 2.55A RESOLUTION REMARK 900 RELATED ID: 2XAI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ANKYRIN REPEAT AND SOCS BOX- CONTAINING REMARK 900 PROTEIN 9 (ASB9) IN COMPLEX WITH ELONGINB AND ELONGINC REMARK 900 RELATED ID: 3ZRC RELATED DB: PDB REMARK 900 PVHL54-213-ELOB-ELOC COMPLEX (4R)-4-HYDROXY-1-[(3- METHYLISOXAZOL-5- REMARK 900 YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL )BENZYL]-L-PROLINAMIDE BOUND REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLY 52 AND SER 53 FROM EXPRESSION TAG REMARK 999 EXTRA M AT N-TERMINUS CONSEQUENCE OF CLONING. DBREF 3ZTC A 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 3ZTC B 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 3ZTC C 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 3ZTC D 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 3ZTC E 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 3ZTC F 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 3ZTC G 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 3ZTC H 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 3ZTC I 54 213 UNP P40337 VHL_HUMAN 54 213 DBREF 3ZTC J 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 3ZTC K 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 3ZTC L 54 213 UNP P40337 VHL_HUMAN 54 213 SEQADV 3ZTC MET B 16 UNP Q15369 CLONING ARTIFACT SEQADV 3ZTC GLY C 51 UNP P40337 EXPRESSION TAG SEQADV 3ZTC SER C 52 UNP P40337 EXPRESSION TAG SEQADV 3ZTC HIS C 53 UNP P40337 EXPRESSION TAG SEQADV 3ZTC MET E 16 UNP Q15369 CLONING ARTIFACT SEQADV 3ZTC GLY F 51 UNP P40337 EXPRESSION TAG SEQADV 3ZTC SER F 52 UNP P40337 EXPRESSION TAG SEQADV 3ZTC HIS F 53 UNP P40337 EXPRESSION TAG SEQADV 3ZTC MET H 16 UNP Q15369 CLONING ARTIFACT SEQADV 3ZTC GLY I 51 UNP P40337 EXPRESSION TAG SEQADV 3ZTC SER I 52 UNP P40337 EXPRESSION TAG SEQADV 3ZTC HIS I 53 UNP P40337 EXPRESSION TAG SEQADV 3ZTC MET K 16 UNP Q15369 CLONING ARTIFACT SEQADV 3ZTC GLY L 51 UNP P40337 EXPRESSION TAG SEQADV 3ZTC SER L 52 UNP P40337 EXPRESSION TAG SEQADV 3ZTC HIS L 53 UNP P40337 EXPRESSION TAG SEQRES 1 A 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 A 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 A 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 A 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 A 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 A 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 A 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 A 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 A 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 A 118 GLN SEQRES 1 B 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 B 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 B 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 B 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 B 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 B 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 B 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 B 97 ALA ASN PHE LEU ASP CYS SEQRES 1 C 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 C 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 C 163 CYS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 C 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 C 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 C 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 C 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 C 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 C 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 C 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 C 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 C 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 C 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 D 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 D 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 D 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 D 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 D 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 D 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 D 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 D 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 D 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 D 118 GLN SEQRES 1 E 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 E 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 E 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 E 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 E 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 E 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 E 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 E 97 ALA ASN PHE LEU ASP CYS SEQRES 1 F 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 F 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 F 163 CYS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 F 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 F 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 F 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 F 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 F 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 F 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 F 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 F 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 F 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 F 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 G 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 G 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 G 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 G 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 G 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 G 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 G 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 G 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 G 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 G 118 GLN SEQRES 1 H 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 H 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 H 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 H 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 H 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 H 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 H 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 H 97 ALA ASN PHE LEU ASP CYS SEQRES 1 I 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 I 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 I 163 CYS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 I 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 I 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 I 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 I 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 I 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 I 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 I 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 I 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 I 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 I 163 ALA HIS GLN ARG MET GLY ASP SEQRES 1 J 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 J 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 J 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 J 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 J 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 J 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 J 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 J 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 J 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 J 118 GLN SEQRES 1 K 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 K 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 K 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 K 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 K 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 K 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 K 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 K 97 ALA ASN PHE LEU ASP CYS SEQRES 1 L 163 GLY SER HIS MET GLU ALA GLY ARG PRO ARG PRO VAL LEU SEQRES 2 L 163 ARG SER VAL ASN SER ARG GLU PRO SER GLN VAL ILE PHE SEQRES 3 L 163 CYS ASN ARG SER PRO ARG VAL VAL LEU PRO VAL TRP LEU SEQRES 4 L 163 ASN PHE ASP GLY GLU PRO GLN PRO TYR PRO THR LEU PRO SEQRES 5 L 163 PRO GLY THR GLY ARG ARG ILE HIS SER TYR ARG GLY HIS SEQRES 6 L 163 LEU TRP LEU PHE ARG ASP ALA GLY THR HIS ASP GLY LEU SEQRES 7 L 163 LEU VAL ASN GLN THR GLU LEU PHE VAL PRO SER LEU ASN SEQRES 8 L 163 VAL ASP GLY GLN PRO ILE PHE ALA ASN ILE THR LEU PRO SEQRES 9 L 163 VAL TYR THR LEU LYS GLU ARG CYS LEU GLN VAL VAL ARG SEQRES 10 L 163 SER LEU VAL LYS PRO GLU ASN TYR ARG ARG LEU ASP ILE SEQRES 11 L 163 VAL ARG SER LEU TYR GLU ASP LEU GLU ASP HIS PRO ASN SEQRES 12 L 163 VAL GLN LYS ASP LEU GLU ARG LEU THR GLN GLU ARG ILE SEQRES 13 L 163 ALA HIS GLN ARG MET GLY ASP HET TR0 C1205 31 HET TR0 F1205 31 HET TR0 I1207 31 HET TR0 L1205 31 HETNAM TR0 (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3- HETNAM 2 TR0 METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE FORMUL 13 TR0 4(C24 H25 N3 O4) FORMUL 17 HOH *73(H2 O) HELIX 1 1 THR A 23 LYS A 36 1 14 HELIX 2 2 PRO A 38 ASP A 40 5 3 HELIX 3 3 THR A 56 GLY A 61 1 6 HELIX 4 4 ARG B 33 LEU B 37 1 5 HELIX 5 5 SER B 39 LEU B 46 1 8 HELIX 6 6 PRO B 66 THR B 84 1 19 HELIX 7 7 ALA B 96 ASP B 111 1 16 HELIX 8 8 THR C 157 SER C 168 1 12 HELIX 9 9 LYS C 171 LEU C 178 5 8 HELIX 10 10 VAL C 181 ASP C 190 1 10 HELIX 11 11 ASN C 193 GLN C 203 1 11 HELIX 12 12 THR D 23 LYS D 36 1 14 HELIX 13 13 PRO D 38 ASP D 40 5 3 HELIX 14 14 ARG E 33 THR E 38 1 6 HELIX 15 15 SER E 39 LEU E 46 1 8 HELIX 16 16 PRO E 66 THR E 84 1 19 HELIX 17 17 ALA E 96 ASP E 111 1 16 HELIX 18 18 THR F 157 SER F 168 1 12 HELIX 19 19 LYS F 171 LEU F 178 5 8 HELIX 20 20 VAL F 181 ASP F 190 1 10 HELIX 21 21 ASN F 193 GLN F 203 1 11 HELIX 22 22 THR G 23 LYS G 36 1 14 HELIX 23 23 PRO G 38 ASP G 40 5 3 HELIX 24 24 THR G 56 GLY G 61 1 6 HELIX 25 25 THR G 63 ALA G 67 5 5 HELIX 26 26 PRO G 100 LYS G 104 5 5 HELIX 27 27 ARG H 33 LEU H 37 1 5 HELIX 28 28 SER H 39 LEU H 46 1 8 HELIX 29 29 PRO H 66 THR H 84 1 19 HELIX 30 30 ALA H 96 GLU H 98 5 3 HELIX 31 31 ILE H 99 ASP H 111 1 13 HELIX 32 32 THR I 157 VAL I 170 1 14 HELIX 33 33 LYS I 171 LEU I 178 5 8 HELIX 34 34 VAL I 181 ASP I 190 1 10 HELIX 35 35 ASN I 193 ARG I 205 1 13 HELIX 36 36 THR J 23 LYS J 36 1 14 HELIX 37 37 PRO J 38 GLN J 42 5 5 HELIX 38 38 THR J 56 GLY J 61 1 6 HELIX 39 39 ARG K 33 LEU K 37 1 5 HELIX 40 40 SER K 39 MET K 45 1 7 HELIX 41 41 PRO K 66 THR K 84 1 19 HELIX 42 42 ILE K 99 ASP K 111 1 13 HELIX 43 43 THR L 157 VAL L 170 1 14 HELIX 44 44 LYS L 171 LEU L 178 5 8 HELIX 45 45 VAL L 181 ASP L 190 1 10 HELIX 46 46 ASN L 193 GLN L 203 1 11 SHEET 1 AA 8 GLN A 49 LEU A 50 0 SHEET 2 AA 8 GLN A 42 LYS A 46 -1 O LYS A 46 N GLN A 49 SHEET 3 AA 8 ALA A 73 PHE A 79 -1 O GLY A 76 N TYR A 45 SHEET 4 AA 8 ASP A 2 ARG A 9 1 O PHE A 4 N ALA A 73 SHEET 5 AA 8 THR A 12 LYS A 19 -1 O THR A 12 N ARG A 9 SHEET 6 AA 8 GLU B 28 LYS B 32 1 O GLU B 28 N THR A 13 SHEET 7 AA 8 TYR B 18 ILE B 22 -1 O VAL B 19 N VAL B 31 SHEET 8 AA 8 GLU B 59 ASN B 61 1 O VAL B 60 N ILE B 22 SHEET 1 CA 4 GLY C 106 TYR C 112 0 SHEET 2 CA 4 PRO C 71 ASN C 78 -1 O SER C 72 N SER C 111 SHEET 3 CA 4 ILE C 147 THR C 152 1 O ILE C 147 N ILE C 75 SHEET 4 CA 4 LEU C 129 VAL C 130 -1 O LEU C 129 N THR C 152 SHEET 1 CB 3 PRO C 95 PRO C 97 0 SHEET 2 CB 3 VAL C 84 LEU C 89 -1 O TRP C 88 N GLN C 96 SHEET 3 CB 3 LEU C 116 ASP C 121 -1 O LEU C 116 N LEU C 89 SHEET 1 DA 7 GLN D 42 TYR D 45 0 SHEET 2 DA 7 ALA D 73 PHE D 79 -1 O GLY D 76 N TYR D 45 SHEET 3 DA 7 ASP D 2 ARG D 9 1 O PHE D 4 N ALA D 73 SHEET 4 DA 7 THR D 12 LYS D 19 -1 O THR D 12 N ARG D 9 SHEET 5 DA 7 GLU E 28 LYS E 32 1 O GLU E 28 N THR D 13 SHEET 6 DA 7 TYR E 18 ILE E 22 -1 O VAL E 19 N VAL E 31 SHEET 7 DA 7 GLU E 59 ASN E 61 1 O VAL E 60 N ILE E 22 SHEET 1 FA 4 GLY F 106 TYR F 112 0 SHEET 2 FA 4 PRO F 71 ASN F 78 -1 O SER F 72 N SER F 111 SHEET 3 FA 4 ILE F 147 THR F 152 1 O ILE F 147 N ILE F 75 SHEET 4 FA 4 LEU F 129 VAL F 130 -1 O LEU F 129 N THR F 152 SHEET 1 FB 3 PRO F 95 PRO F 97 0 SHEET 2 FB 3 VAL F 84 LEU F 89 -1 O TRP F 88 N GLN F 96 SHEET 3 FB 3 TRP F 117 ASP F 121 -1 O LEU F 118 N VAL F 87 SHEET 1 GA 8 GLN G 49 LEU G 50 0 SHEET 2 GA 8 GLN G 42 LYS G 46 -1 O LYS G 46 N GLN G 49 SHEET 3 GA 8 ALA G 73 PHE G 79 -1 O GLY G 76 N TYR G 45 SHEET 4 GA 8 ASP G 2 ARG G 9 1 O PHE G 4 N ALA G 73 SHEET 5 GA 8 THR G 12 LYS G 19 -1 O THR G 12 N ARG G 9 SHEET 6 GA 8 GLU H 28 LYS H 32 1 O GLU H 28 N THR G 13 SHEET 7 GA 8 TYR H 18 ILE H 22 -1 O VAL H 19 N VAL H 31 SHEET 8 GA 8 GLU H 59 ASN H 61 1 O VAL H 60 N ILE H 22 SHEET 1 IA 4 GLY I 106 TYR I 112 0 SHEET 2 IA 4 PRO I 71 ASN I 78 -1 O SER I 72 N SER I 111 SHEET 3 IA 4 ILE I 147 THR I 152 1 O ILE I 147 N ILE I 75 SHEET 4 IA 4 LEU I 129 VAL I 130 -1 O LEU I 129 N THR I 152 SHEET 1 IB 3 PRO I 95 PRO I 97 0 SHEET 2 IB 3 VAL I 84 LEU I 89 -1 O TRP I 88 N GLN I 96 SHEET 3 IB 3 LEU I 116 ASP I 121 -1 O LEU I 116 N LEU I 89 SHEET 1 JA 8 GLN J 49 LEU J 50 0 SHEET 2 JA 8 ARG J 43 LYS J 46 -1 O LYS J 46 N GLN J 49 SHEET 3 JA 8 ALA J 73 ALA J 78 -1 O GLY J 76 N TYR J 45 SHEET 4 JA 8 ASP J 2 ARG J 9 1 O PHE J 4 N ALA J 73 SHEET 5 JA 8 THR J 12 LYS J 19 -1 O THR J 12 N ARG J 9 SHEET 6 JA 8 GLU K 28 LYS K 32 1 O GLU K 28 N THR J 13 SHEET 7 JA 8 TYR K 18 ILE K 22 -1 O VAL K 19 N VAL K 31 SHEET 8 JA 8 GLU K 59 ASN K 61 1 O VAL K 60 N ILE K 22 SHEET 1 LA 4 GLY L 106 TYR L 112 0 SHEET 2 LA 4 PRO L 71 ASN L 78 -1 O SER L 72 N SER L 111 SHEET 3 LA 4 ILE L 147 THR L 152 1 O ILE L 147 N ILE L 75 SHEET 4 LA 4 LEU L 129 VAL L 130 -1 O LEU L 129 N THR L 152 SHEET 1 LB 3 PRO L 95 PRO L 97 0 SHEET 2 LB 3 VAL L 84 LEU L 89 -1 O TRP L 88 N GLN L 96 SHEET 3 LB 3 LEU L 116 ASP L 121 -1 O LEU L 116 N LEU L 89 CISPEP 1 GLU D 98 LEU D 99 0 -21.47 CISPEP 2 ASP F 143 GLY F 144 0 -13.22 CISPEP 3 ASP G 82 ASP G 83 0 -18.20 SITE 1 AC1 12 TRP I 88 PHE I 91 TYR I 98 PRO I 99 SITE 2 AC1 12 ILE I 109 HIS I 110 SER I 111 TYR I 112 SITE 3 AC1 12 HIS I 115 TRP I 117 HOH I2001 HOH I2002 SITE 1 AC2 11 TRP C 88 TYR C 98 PRO C 99 ILE C 109 SITE 2 AC2 11 HIS C 110 SER C 111 TYR C 112 HIS C 115 SITE 3 AC2 11 TRP C 117 HOH C2001 ARG L 182 SITE 1 AC3 12 TRP F 88 PHE F 91 TYR F 98 PRO F 99 SITE 2 AC3 12 ARG F 107 ILE F 109 HIS F 110 SER F 111 SITE 3 AC3 12 TYR F 112 HIS F 115 TRP F 117 HOH F2002 SITE 1 AC4 12 TRP L 88 PHE L 91 TYR L 98 PRO L 99 SITE 2 AC4 12 ILE L 109 HIS L 110 SER L 111 TYR L 112 SITE 3 AC4 12 HIS L 115 TRP L 117 HOH L2002 HOH L2001 CRYST1 94.091 94.091 366.724 90.00 90.00 90.00 P 41 2 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010628 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010628 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002727 0.00000